HMABs ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
113筋ジストロフィー1

113. 筋ジストロフィー


臨床試験数 : 646 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2011-000176-33-IT
(EUCTR)
14/02/201123/02/2011Cell Therapy Of Duchenne Muscular Dystrophy by intra-arterial delivery of HLA-identical allogeneic mesoangioblasts - NDCell Therapy Of Duchenne Muscular Dystrophy by intra-arterial delivery of HLA-identical allogeneic mesoangioblasts - ND Duchenne Muscolar Dystrophy
MedDRA version: 9.1;Level: PT;Classification code 10013801
INN or Proposed INN: Tacrolimus
Product Name: hMABs
Other descriptive name: HLA-identical allogeneic mesoangioblasts
Product Name: hMABs
Other descriptive name: HLA-identical allogeneic mesoangioblasts
Product Name: hMABs
Other descriptive name: HLA-identical allogeneic mesoangioblasts
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABORNULLAuthorised-recruitment may be ongoing or finishedFemale: no
Male: yes
Italy